Many studies have demonstrated that Chi3l1 is a reliable biomarker and promising therapeutic target for blood vessel-related inflammatory diseases such as atherosclerosis, coronary artery disease, stroke, and hypertension (Figure 1) [104]. This evidence concerns the gene CHI3L1 and coronary artery disorder.